查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032450

嗜睡症治療市場報告：按類型、疾病、治療方法和地區分類（2026-2034 年）

Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球嗜睡症治療市場規模達38億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到67億美元，2026年至2034年的複合年成長率為6.38%。嗜睡症認知度和診斷率的提高、睡眠障礙盛行率的上升、藥物研發的持續進展以及有利的法規環境是推動市場成長的主要因素。

發作性睡病藥物是指用於治療慢性睡眠障礙的藥物。這種疾病的特徵是白天過度嗜睡（EDS）、猝倒（突然肌肉無力）、睡眠癱瘓、幻覺、睡眠片段化和失眠。其他症狀包括無意識的自動行為、視力模糊、複視、眼瞼下垂和精神功能障礙。發作性睡病患者的每日睡眠時間通常與健康人相似，但睡眠品質較差。常用的發作性睡病藥物包括中樞神經系統興奮劑、羥考酮鈉、選擇性血清素再回收抑制劑（SSRIs）和三環抗憂鬱藥物。這些藥物有助於改善成年患者的清醒狀態，並減少幻覺、嗜睡和猝倒症狀。

嗜睡症治療市場趨勢：

全球嗜睡症盛行率的上升是推動市場成長的主要因素之一。這主要是由於久坐的生活方式和繁忙的工作安排，導致睡眠相關疾病的發生率顯著增加。此外，公眾健康意識的提高和對現有治療方法認知度的提高也促進了市場成長。同時，羥考酮鈉在兒童嗜睡症治療的廣泛應用也推動了市場成長。嗜睡症診斷技術的顯著進步也是推動市場成長的重要因素。製藥公司也在研發具有長期療效且副作用較小的製劑。其他因素，例如易患此類疾病的老年人口不斷成長以及神經病學領域廣泛的研發活動，預計也將推動市場成長。

市場區隔:

本報告分析了全球嗜睡症治療市場各細分領域的關鍵趨勢，並對2026年至2034年進行了全球、區域和國家層面的預測。市場按類型、疾病類型和治療類型進行細分。

按類型細分：

  • 猝倒症
  • 無猝倒症的嗜睡症
  • 續發性嗜睡症

按疾病類型細分：

  • 白天極度嗜睡
  • 猝倒症
  • 其他

依治療方法分類：

  • 奧克西巴特
  • 中樞神經系統興奮劑
  • 三環抗憂鬱藥物
  • 選擇性血清素再回收抑制劑
  • 其他

按地區分類：

  • 北美洲
  • 我們
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

競爭格局：

本報告也檢視了該行業的競爭格局，並介紹了主要參與者的概況，例如 Avadel Pharmaceuticals plc、Axsome Therapeutics Inc.、Bioprojet Pharma、Graymark Healthcare Inc.、Jazz Pharmaceuticals plc、Ligand Pharmaceuticals Incorporated、Novartis AG、 檢驗. Ltd.

本報告解答的主要問題

1. 嗜睡症治療市場規模有多大？

2. 嗜睡症治療市場的未來前景如何？

3. 哪些因素是推動嗜睡症治療市場發展的主要因素？

4. 在嗜睡症治療市場中，哪個地區佔據最大的市佔率？

5. 全球嗜睡症治療市場的主要參與者有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球嗜睡症治療市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 猝倒型嗜睡症
  • 無猝倒症的嗜睡症
  • 續發性嗜睡症

第7章 市場區隔：依疾病類型分類

  • 白天極度嗜睡
  • 猝倒症
  • 其他

第8章 市場區隔：依治療領域分類

  • 奧昔巴特鈉
  • 中樞神經系統興奮劑
  • 三環抗憂鬱藥物
  • 選擇性血清素再回收抑制劑
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Avadel Pharmaceuticals plc
    • Axsome Therapeutics Inc.
    • Bioprojet Pharma
    • Graymark Healthcare Inc.
    • Jazz Pharmaceuticals plc
    • Ligand Pharmaceuticals Incorporated
    • Novartis AG
    • SHIONOGI & Co. Ltd.
    • Takeda Pharmaceutical Company Limited
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112026A5685

The global narcolepsy drugs market size reached USD 3.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.38% during 2026-2034. The increasing awareness and diagnosis of narcolepsy, growing prevalence of sleep disorders, ongoing advancements in drug development, and favorable regulatory environment are primarily driving the market's growth.

Narcolepsy drugs refer to pharmaceutical medicines used for the treatment of chronic sleep disorders. The disorder is characterized by excessive daytime sleepiness (EDS), cataplexy or sudden loss of muscle strength, sleep paralysis, hallucinations, fragmented sleep and insomnia. Additional symptoms may include automatic behaviors without conscious awareness, blurred vision, double vision or droopy eyelids and disturbed mental functioning. Patients suffering from narcolepsy tend to sleep the same number of hours per day as normal individuals; however, sleep quality tends to be poorer. Some of the commonly used narcolepsy drugs include central nervous system stimulants, sodium oxybate, selective serotonin reuptake inhibitors and tricyclic antidepressants. These drugs aid in improving wakefulness in adult patients and minimizing hallucinations, sleepiness and cataplexy.

Narcolepsy Drugs Market Trends:

The increasing prevalence of narcolepsy across the globe is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the working population, which, in turn, is significantly increasing the incidences of sleep-related disorders. Moreover, rising health consciousness among the masses and the increasing awareness regarding the available treatment alternatives are providing a thrust to the market growth. In line with this, the widespread adoption of sodium oxybate for the treatment of narcolepsy in children is also contributing to the growth of the market. Additionally, significant improvements in the diagnostic technologies for narcolepsy are acting as other growth-inducing factors. Pharmaceutical manufacturers are also developing variants with long-term benefits and reduced side effects. Other factors, including the rising geriatric population, which is more susceptible to such ailments, along with extensive research and development (R&D) activities in the field of neurology, are anticipated to drive the market toward growth.

Market Segmentation:

This report provides an analysis of the key trends in each sub-segment of the global narcolepsy drugs market report, along with forecasts at the global, regional, and country levels from 2026-2034. The report categorizes the market based on type, disease type, and therapeutic type.

Breakup by Type:

  • Narcolepsy with Cataplexy
  • Narcolepsy without Cataplexy
  • Secondary Narcolepsy

Breakup by Disease Type:

  • Daytime Extreme Sleepiness
  • Cataplexia
  • Others

Breakup by Therapeutic Type:

  • Sodium Oxybate
  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Selective Serotonin Reuptake Inhibitor
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. How big is the narcolepsy drugs market?

2. What is the future outlook of narcolepsy drugs market?

3. What are the key factors driving the narcolepsy drugs market?

4. Which region accounts for the largest narcolepsy drugs market share?

5. Which are the leading companies in the global narcolepsy drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Narcolepsy Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Narcolepsy with Cataplexy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Narcolepsy without Cataplexy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Secondary Narcolepsy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Disease Type

  • 7.1 Daytime Extreme Sleepiness
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cataplexia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Therapeutic Type

  • 8.1 Sodium Oxybate
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Central Nervous System Stimulants
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Tricyclic Antidepressants
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Selective Serotonin Reuptake Inhibitor
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Avadel Pharmaceuticals plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Axsome Therapeutics Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Bioprojet Pharma
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Graymark Healthcare Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Jazz Pharmaceuticals plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Ligand Pharmaceuticals Incorporated
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 SHIONOGI & Co. Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Takeda Pharmaceutical Company Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teva Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Narcolepsy Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Narcolepsy Drugs Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Narcolepsy Drugs Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Narcolepsy Drugs Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Narcolepsy Drugs Market: Breakup by Disease Type (in %), 2025
  • Figure 6: Global: Narcolepsy Drugs Market: Breakup by Therapeutic Type (in %), 2025
  • Figure 7: Global: Narcolepsy Drugs Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Narcolepsy Drugs (Cataplexia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Narcolepsy Drugs (Cataplexia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Narcolepsy Drugs (Other Disease Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Narcolepsy Drugs (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Narcolepsy Drugs (Sodium Oxybate) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Narcolepsy Drugs (Sodium Oxybate) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Narcolepsy Drugs (Other Therapeutic Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Narcolepsy Drugs (Other Therapeutic Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Narcolepsy Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Narcolepsy Drugs Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Narcolepsy Drugs Industry: SWOT Analysis
  • Figure 80: Global: Narcolepsy Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Narcolepsy Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Narcolepsy Drugs Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Narcolepsy Drugs Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Narcolepsy Drugs Market Forecast: Breakup by Disease Type (in Million USD), 2026-2034
  • Table 4: Global: Narcolepsy Drugs Market Forecast: Breakup by Therapeutic Type (in Million USD), 2026-2034
  • Table 5: Global: Narcolepsy Drugs Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Narcolepsy Drugs Market: Competitive Structure
  • Table 7: Global: Narcolepsy Drugs Market: Key Players